Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
about
Immunizing against Anogenital Cancer: HPV VaccinesEconomic impact of thermostable vaccines.The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making
P2860
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@ast
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@en
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@nl
type
label
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@ast
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@en
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@nl
prefLabel
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@ast
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@en
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@nl
P2093
P2860
P1476
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.
@en
P2093
Florian Semmelmann
Kimberly J Hassett
Megan C Cousins
Natalie M Meinerz
Robert L Garcea
Theodore W Randolph
P2860
P304
P356
10.1016/J.EJPB.2015.05.009
P407
P577
2015-05-18T00:00:00Z